In a move aimed at addressing growing concerns over brand name extensions in the pharmaceutical sector, the Drugs ...

The Food and Drug Administration has recalled a popular treatment for high blood pressure. The agency said that bottles of ...

The FDA recalled multiple lots of blood pressure medication Ziac by Glenmark due to possible cross-contamination ...

DCC suggests stakeholder consultation on use of same brand name for multiple drug formulations: Our Bureau, New Delhi Saturday, December 6, 2025, 08:00 Hrs [IST] The Drugs Consult ...

Glenmark's Ziac blood pressure tablets contaminated with cholesterol drug ezetimibe prompts FDA recall affecting multiple ...

The Food and Drug Administration (FDA) classified the recall with a Class lll risk level, suggesting that exposure to the ...

Blood pressure medicine has been recalled because it may be cross-contaminated with another medication, according to reports.

Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.

Neither the FDA nor Glenmark Pharmaceuticals have issued guidance for consumers who may have the medication involved in this ...

The Cleveland Clinic explains high doses can come with outsized risk—at times "fatal," they say—compared with other types of antihistamine.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...